Upload Avatar (500 x 500)
Xiao Yu
xiaoyu523@smu.edu.cn
English, Chinese
Guangdong
Southern Medical University
Basic Medical Sciences
  • 2023: Appointed as a young scholar in the national talent project by the Ministry of Education
  • 2024: Received the 12th Chinese Society of Immunology Academic Award for Young Scholars
  • 2019: Appointed as a 'Young Pearl River Scholar' in Guangdong Province
Research on the correlation between the innate immune system recognition and regulation mechanisms and infectious diseases
  • The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti-T. Gondii Immunity and Tumor Immunotherapy, Hu Z., Zhang Y., Xie Y., Yang J., Tang H., Fan B., Zeng K., Han Z., Lu J., Jiang H., Peng W., Li H., Chen H., Wu S., Shen B., Lun Z.R., and Yu X., 2024
  • Dual nature of type I interferon responses and feedback regulations by SOCS1 dictate malaria mortality, Lu J., Hu Z., Jiang H., Wen Z., Li H., Li J., Zeng K., Xie Y., Chen H., Su X.Z., Cai C., and Yu X., 2024
  • Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy, Jiang H., Xie Y., Lu J., Li H., Zeng K., Hu Z., Wu D., Yang J., Yao Z., Chen H., Gong X., and Yu X., 2024
  • VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation, Hu Z., Xie Y., Lu J., Yang J., Zhang J., Jiang H., Li H., Zhang Y., Wu D., Zeng K., Bai X., and Yu X., 2023
  • Natural killer cells: Warriors against malaria, Li H. and Yu X., 2023
  • Vangl2 suppresses NF-kB signaling and ameliorates sepsis by targeting p65 for NDP52-mediated autophagic degradation, Lu J., Zhang J., Jiang H., Hu Z., He L., Yang J., Xie Y., Wu D., Li H., Zeng K., Tan P., Xiao Q., Song Z., Bai X., and Yu X., 2023
  • SHIP1 modulates antimalarial immunity by bridging the crosstalk between type I IFN signaling and autophagy, Li H., Yang S., Zeng K., Guo J., Wu J., Jiang H., Xie Y., Lu J., Hu Z., Yang J., Su X., Cui J., and Yu X., 2023
  • Function and regulation of cGAS-STING signaling in infectious diseases, Du Y., Hu Z., Luo Y., Wang H.Y., Yu X., and Wang R.F., 2023
  • Activation of cGAS-STING by Lethal Malaria N67C Dictates Immunity and Mortality through Induction of CD11b(+) Ly6C(hi) Proinflammatory Monocytes, Du Y., Luo Y., Hu Z., Lu J., Liu X., Xing C., Wu J., Duan T., Chu J., Wang H.Y., Su X.Z., Yu X., and Wang R.F., 2022
  • Inflammasome Activation Dampens Type I IFN Signaling to Strengthen Anti-Toxoplasma Immunity, Hu Z., Wu D., Lu J., Zhang Y., Yu S.M., Xie Y., Li H., Yang J., Lai D.H., Zeng K., Jiang H., Lun Z.R., and Yu X., 2022
  • Friedelin Alleviates the Pathogenesis of Collagenase-Induced Tendinopathy in Mice by Promoting the Selective Autophagic Degradation of p65, Jiang H., Lin X., Liang W., Li Y., and Yu X., 2022
  • Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARgamma to inhibit NF-kappaB signalling pathway, Lu J., Guan H., Wu D., Hu Z., Zhang H., Jiang H., Yu J., Zeng K., Li H., Zhang H., Pan C., Cai D., and Yu X., 2021
  • Accelerator or Brake: Immune Regulators in Malaria, Cai C., Hu Z., and Yu X., 2020
  • A mathematic model to reveal delicate cross-regulation between MAVS/STING, inflammasome and MyD88-dependent type I interferon signalling, Cai C. and Yu X., 2020
  • Inflammasome activation negatively regulates MyD88-IRF7 type I IFN signaling and anti-malaria immunity, Yu X., Du Y., Cai C., Cai B., Zhu M., Xing C., Tan P., Lin M., Wu J., Li J., Wang M., Wang H.Y., Su X.Z., and Wang R.F., 2018
  • A novel miR-200b-3p/p38IP pair regulates monocyte/macrophage differentiation, Yu X., Wang Q.L., Li Y.F., Wang X.D., Xu A., and Li Y., 2016
  • Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality, Yu X., Cai B., Wang M., Tan P., Ding X., Wu J., Li J., Li Q., Liu P., Xing C., Wang H.Y., Su X.Z., and Wang R.F., 2016
Infection Immunity Innate Immunity Type I Interferon Inflammasome Regulation Mechanism Host Response Immune Homeostasis Therapeutic Targets

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.